Development of non-biohazardous p24 antigen expressing synthetic cells as a reference control alternative to HIV+ donor samples

Fill out the form below to download the case study.

By using this website, you agree to the storing of cookies on your device. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookie Policy.